APA (7th ed.) Citation

JX, L., K, Y., LX, Y., Y, Z., BF, X., YL, S., . . . HY, T. (2026). First case report of transformation of adenocarcinoma to adenosquamous carcinoma with giant-cell carcinoma harboring HER2 mutation after zongertinib (BI 1810631) resistance. Lung cancer (Amsterdam, Netherlands), 216, 108912. https://doi.org/10.1016/j.lungcan.2026.108912

Chicago Style (17th ed.) Citation

JX, Lin, Yin K, Yan LX, Zhu Y, Xu BF, Sun YL, Wu YL, and Tu HY. "First Case Report of Transformation of Adenocarcinoma to Adenosquamous Carcinoma with Giant-cell Carcinoma Harboring HER2 Mutation After Zongertinib (BI 1810631) Resistance." Lung Cancer (Amsterdam, Netherlands) 216 (2026): 108912. https://doi.org/10.1016/j.lungcan.2026.108912.

MLA (9th ed.) Citation

JX, Lin, et al. "First Case Report of Transformation of Adenocarcinoma to Adenosquamous Carcinoma with Giant-cell Carcinoma Harboring HER2 Mutation After Zongertinib (BI 1810631) Resistance." Lung Cancer (Amsterdam, Netherlands), vol. 216, 2026, p. 108912, https://doi.org/10.1016/j.lungcan.2026.108912.